These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32899449)

  • 41. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
    Sun MY; Wang L; Shen ZY
    Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploration of pro-apoptotic effect of Thymoquinone on oral squamous cell carcinoma cells through PI3K/Akt signaling pathway.
    Ren X; Luo W
    Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):61-64. PubMed ID: 30782296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.
    Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X
    Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
    Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
    Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway.
    Sun Q; Zhang T; Xiao Q; Mei B; Zhang X
    Bioengineered; 2022 Mar; 13(3):6500-6508. PubMed ID: 35220896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo.
    Zou Y; Ge M; Wang X
    Biochem Biophys Res Commun; 2017 Aug; 490(2):385-392. PubMed ID: 28623128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypomethylation-associated Sox11 upregulation promotes oncogenesis via the PI3K/AKT pathway in OLP-associated OSCC.
    Liu Y; Cao P; Xiao L; Tang N; Fei W; Li X
    J Cell Mol Med; 2024 Jul; 28(14):e18556. PubMed ID: 39039706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resveratrol acts via melanoma-associated antigen A12 (MAGEA12)/protein kinase B (Akt) signaling to inhibit the proliferation of oral squamous cell carcinoma cells.
    Shang Y; Jiang YL; Ye LJ; Chen LN; Ke Y
    Bioengineered; 2021 Dec; 12(1):2253-2262. PubMed ID: 34085601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model.
    Menu E; Kooijman R; Van Valckenborgh E; Asosingh K; Bakkus M; Van Camp B; Vanderkerken K
    Br J Cancer; 2004 Mar; 90(5):1076-83. PubMed ID: 14997210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Campothecin suppresses cell proliferation and migration in head and neck squamous cell carcinoma by blocking RAB27A-mediated phosphatidylinositol 3 kinase (PI3K)/protein kinase B (AKT) pathway.
    Zhao Y; Wang Y; Zhao L; Qu L; Zheng JH
    J Physiol Pharmacol; 2024 Apr; 75(2):205-213. PubMed ID: 38736267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hedgehog pathway activation in oral squamous cell carcinoma: cancer-associated fibroblasts exhibit nuclear GLI-1 localization.
    Guimaraes VSN; Vidal MTA; de Faro Valverde L; de Oliveira MG; de Oliveira Siquara da Rocha L; Coelho PLC; Soares FA; de Freitas Souza BS; Bezerra DP; Coletta RD; Pereira TA; Dos Santos JN; Gurgel Rocha CA
    J Mol Histol; 2020 Dec; 51(6):675-684. PubMed ID: 33000351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway.
    Lu Y; Lin J; Duan M; Rui Y; Zheng H; Zhu L; Zhu X; Wei J
    Anal Cell Pathol (Amst); 2021; 2021():5228713. PubMed ID: 34926131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of beta-catenin signaling.
    Wang L; Shao YY; Ballock RT
    J Bone Miner Res; 2010 May; 25(5):1138-46. PubMed ID: 20200966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aurora-A down-regulates IkappaBalpha via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival.
    Yao JE; Yan M; Guan Z; Pan CB; Xia LP; Li CX; Wang LH; Long ZJ; Zhao Y; Li MW; Zheng FM; Xu J; Lin DJ; Liu Q
    Mol Cancer; 2009 Nov; 8():95. PubMed ID: 19891769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis.
    Li L; Li JC; Yang H; Zhang X; Liu LL; Li Y; Zeng TT; Zhu YH; Li XD; Li Y; Xie D; Fu L; Guan XY
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8948-E8957. PubMed ID: 30158168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of VEGFR2 and EGFR signaling cooperatively suppresses the proliferation of oral squamous cell carcinoma.
    Onda M; Ota A; Ito K; Ono T; Karnan S; Kato M; Kondo S; Furuhashi A; Hayashi T; Hosokawa Y; Kazaoka Y
    Cancer Med; 2023 Aug; 12(15):16416-16430. PubMed ID: 37341071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-like growth factor-1 promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex.
    Mairet-Coello G; Tury A; DiCicco-Bloom E
    J Neurosci; 2009 Jan; 29(3):775-88. PubMed ID: 19158303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
    Wang M; Feng Z; Li X; Sun S; Lu L
    Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.